Results 141 to 150 of about 97,830 (260)

The early presentation and management of rheumatoid arthritis cases in primary care [PDF]

, 2011
Recent NICE guidance has emphasised the importance of early recognition and referral of patients with inflammatory arthritis so that disease modifying treatment can be promptly initiated.
Cassell, Jackie, Davies, Kevin, Nicholson, Amanda, Rait, Greta, Smith, Helen, Tate, Rosemary   +5 more
core   +1 more source

Quantitative Muscle Magnetic Resonance Imaging Demonstrates Resolution of Muscle Edema in Refractory Dermatomyositis: A Post Hoc Analysis of a Proof‐of‐Concept Clinical Trial of Tofacitinib

ACR Open Rheumatology, Volume 8, Issue 5, May 2026.
Objective To evaluate changes in muscle edema using short‐tau inversion recovery (STIR) imaging and quantitative diffusion‐weighted imaging (DWI) with apparent diffusion coefficient (ADC) mapping in patients with refractory dermatomyositis (DM) treated with tofacitinib. Methods This post hoc imaging analysis included patients from a 12‐week, open‐label
Mona Dabiri, Anshula Nallapati, Marwin Groener, Patrick Debs, Jemima Albayda, Eleni Tiniakou, Lisa Christopher‐Stine, Laura Fayad, Julie J. Paik   +8 more
wiley   +1 more source

Pulmonary hemosiderosis with juvenile rheumatoid arthritis: a case report

The Turkish Journal of Pediatrics, 2000
Pulmonary hemosiderosis may rarely be associated with juvenile rheumatoid arthritis or can develop during the course of the disease. We present a three-year-old boy with severe iron deficiency anemia (without any pulmonary symptoms) and arthralgia
R Topaloğlu, N Kiper, A Göçmen, B Varan, U Saatçi   +4 more
doaj  

Use of Semaglutide and Tirzepatide in Rheumatic and Musculoskeletal Diseases: Insights on Initiation Patterns and Weight Loss From the Rheumatology Informatics System for Effectiveness Registry

ACR Open Rheumatology, Volume 8, Issue 5, May 2026.
Objective Glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) such as semaglutide (SEM) and tirzepatide (TZP) were initially approved for type 2 diabetes management but are increasingly used for weight loss. Limited data exist on real‐world use among patients with rheumatic and musculoskeletal diseases (RMDs).
Nicholas P. McCormick, Cristiano S. Moura, Jingyi Zhang, Emily E. Holladay, Fenglong Xie, Tapan Mehta, Joshua F. Baker, Jeffrey R. Curtis   +7 more
wiley   +1 more source

RNA Modifications: Current Understandings and Future Perspectives

MedComm, Volume 7, Issue 5, May 2026.
Types of RNA modification. We have summarized the currently common types of RNA modifications, including ac4C, m6A, m1A, m5C, m3C, m7G, and ψ, and visually characterized their features through structural formulas. The characteristic structures are marked with a background color different from the background color.
Shiyu Xiao, Tingwen Xiang, Chuan Yang, Xiaohua Wang, Gang Huang, Fei Luo, Zhao Xie, Yueqi Chen   +7 more
wiley   +1 more source

Intestinal Atresia in Finland: Maternal Risk Factors, Prevalence, Associated Anomalies and Survival

Acta Paediatrica, Volume 115, Issue 5, Page 1070-1076, May 2026.
ABSTRACT Aim We aimed to investigate prevalence, associated anomalies and survival of congenital intestinal atresia and to examine maternal risk factors for jejunoileal atresia (JIA). Methods All children born with, or pregnancies terminated because of, JIA or colonic atresia (CA) in Finland during 1987–2019 were identified from the Finnish Register of
Esko Tahkola, Arimatias Raitio, Ilkka Helenius, Johanna Syvänen, Teemu Kemppainen, Eliisa Löyttyniemi, Maarit K. Leinonen, Mika Gissler, Topi Luoto, Mikko P. Pakarinen   +9 more
wiley   +1 more source

Real‐World Efficacy and Safety of Tofacitinib for Patients With Alopecia Areata: A Retrospective Multi‐Center Cohort Study

Clinical and Translational Science, Volume 19, Issue 5, May 2026.
ABSTRACT The approval of baricitinib and ritlecitinib for alopecia areata (AA) marks the beginning of the Janus kinase (JAK) inhibitor era in AA treatment. Tofacitinib, a first‐generation JAK1/3 inhibitor, has theoretical potential to treat AA; however, real‐world evidence, particularly on comparative outcomes across patient subgroups and patient ...
Yifan Jin, Juanmei Cao, Sai Yang, Yinghui Liu, Rong Tang, Yufang Zeng, Changzheng Huang, Ying Luo   +7 more
wiley   +1 more source

How Do Dental Professionals and Students Assess Orthodontic Case Complexity?

European Journal of Dental Education, Volume 30, Issue 2, Page 502-510, May 2026.
ABSTRACT Background Accurately diagnosing and assessing orthodontic case complexity is essential for treatment planning, estimating therapy duration, and determining required expertise. Various indices, such as the American Board of Orthodontics Discrepancy Index (ABO DI), provide objective evaluations.
Giulia Semerari, Antonino Peluso, Anthony Carlino, Francesco Moscagiuri, Michele D'Attilio   +4 more
wiley   +1 more source

Physical activity and quality of life of children and adolescents with juvenile idiopathic arthritis, juvenile systemic lupus erythematosus and juvenile dermatomyositis during the COVID-19 pandemic. [PDF]

J Pediatr (Rio J)
Soares R, Silva FC, Fernandez JD, Fraga MM, Terreri MT, Len CA.   +5 more
europepmc   +1 more source

Juvenile rheumatoid arthritis (Juvenile chronic arthritis)

Dermatology Online Journal, 2001
openaire   +4 more sources